CTRI/2017/11/010529已完成4 期
Comparative Evaluation of Safety and Efficacy of Drotaverine Versus Mebeverine in Irritable Bowel Syndrome â?? A Randomized Double Blind Controlled Study. - Drotin DS/07/15
Walter Bushnell Pvt Ltd0 个研究点目标入组 200 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients between 18 to 80 years of either gender
- •Fulfillment of IBS Rome III criteria
- •Written informed consent
排除标准
- •Failure to meet all inclusion criteria
- •Pregnant females
- •Patients with comorbid diseases, coronary artery disease (CAD), chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF)
- •Patients taking drugs which modify or aggravate symptoms (antidepressants, calcium channel blockers etc)
- •Patients having hypothyroidism & gluten hypersensitivity
- •Any history of fever, passage of blood in stool, loss of weight, any organic disease of GI tract in the recent past
- •Patients on any other concomitant medication for abdominal pain, bowel disturbance or altering gastrointestinal motility
- •Malignancy of any other organ
研究者
相似试验
进行中（未招募）
不适用
Comparison of efficacy and safety of different regimens of sublingual immunotherapy for Ragweed.EUCTR2011-001682-41-ITAZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)45
尚未招募
Unknown
guidewire for ERCPDiseases of the digestive systemKCT0009650Hallym University Medical Center-Dongtan190
已完成
不适用
A preliminary safety and efficacy evaluation of direct delivery of autologous bone marrow-derived cells in Egyptian patients with type 1 diabetes mellitusDigestive SystemType 1 diabetes mellitusISRCTN15591075Wadi EL-Neel hospital (JCI)3
已完成
不适用
To determine the safety and effectiveness of Dandruff ControlOil Shots in dandruff reduction in Healthy Adult HumanSubjects with Dandruff on the scalpCTRI/2022/04/041701Brillare Science Private Limited16
已完成
3 期
A clinical trial to study the effect of primaquine conventional release tablet and primaquine sustained release tablet in prevention of relapse of plasmodium vivax malaria.CTRI/2010/091/000245Ipca Laboratories Ltd360